China Infection Diagnosis Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Infection Diagnosis Market was valued at USD 1.39 billion in 2025 and is projected to reach USD 1.96 billion by 2032, growing at a CAGR of approximately 5% during 2026–2032.
China Infection Diagnosis Market Highlights
| Report Metric | Details |
| Report Name | China Infection Diagnosis Market |
| Market Size 2025 | USD 1.39 billion |
| Market Size 2032 | USD 1.96 billion |
| Absolute Growth 2025–2032 | USD 0.57 billion |
| CAGR 2026–2032 | 5% |
| Peak Annual Growth | 7.3% in 2026 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Diagnostic Type, 2025 | PCR Kits (47% share) |
| Leading Sample Type, 2025 | Blood / Swab (46% share) |
| Leading Infection Type, 2025 | Viral Infections (39% share) |
| Leading Distribution Channel, 2025 | Laboratory Distributors (48% share) |
| Fastest-Growing Diagnostic Type | Rapid Antigen Tests (7.1% CAGR) |
| Fastest-Growing Sample Type | Nasal / Saliva (6.8% CAGR) |
| Fastest-Growing Infection Type | Bacterial / Viral (7.0% CAGR) |
| Fastest-Growing Distribution Channel | Online Diagnostic Suppliers (7.7% CAGR) |
| Growing Sector | Healthcare |
| Key End Users | Hospitals, Laboratories, Medical Facilities, Diagnostic Suppliers |
China Infection Diagnosis Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Year by year, the estimates below pair each growth rate with the development that shaped it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 5.7 | The market experienced strong demand from hospitals and laboratories across the country. |
| 2023 | 3.8 | Growth slowed as the market adjusted to new health standards and testing protocols. |
| 2024 | 4.3 | Increased adoption of rapid antigen tests contributed to a rise in market activity. |
| 2025 | 3.6 | Demand remained steady as healthcare facilities focused on improving diagnostic capabilities. |
| 2026 | 7.3 | A surge in the use of PCR kits is expected to drive growth in the market. |
| 2027 | 5.9 | The market will grow at a slower pace as the focus shifts to long-term testing strategies. |
| 2028 | 4.2 | Demand for blood and plasma samples is projected to increase, supporting market stability. |
| 2029 | 3.0 | Growth will slow as the market faces challenges in meeting rising healthcare standards. |
| 2030 | 6.0 | A renewed focus on rapid testing technologies is anticipated to boost market growth. |
| 2031 | 5.2 | Market growth is expected to decelerate as competition among suppliers intensifies. |
| 2032 | 3.7 | Growth is projected to slow further as new regulations come into effect. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Infection Diagnosis Market Synopsis
Infection Diagnosis in China covers products used to detect pathogens causing infections, including PCR kits and rapid antigen tests. These products play a vital role in diagnosing diseases and monitoring outbreaks. The China Infection Diagnosis Market is expanding due to a large population and increasing healthcare demands. Investments in laboratory infrastructure and the promotion of advanced testing methods are driving this growth. The National Health Commission's initiatives further support the market's expansion, ensuring that diagnostic capabilities meet the rising needs of healthcare facilities.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising prevalence of chronic diseases | Driver | High | PCR Kits |
| Increased government funding for healthcare infrastructure | Driver | High | Laboratory Distributors |
| Growing demand for rapid testing solutions | Opportunity | High | Rapid Antigen Tests |
| Expansion of online diagnostic sales channels | Opportunity | Medium | Online Diagnostic Suppliers |
| Regulatory hurdles in product approval processes | Restraint | High | ELISA Test Kits |
| Limited access to advanced diagnostic technologies in rural areas | Restraint | Medium | Culture Media & Kits |
| Challenges in maintaining product quality and safety standards | Challenge | High | PCR Kits |
| Increasing competition among suppliers leading to price wars | Challenge | Medium | PCR Kits |
Evaluation of Drivers in China Infection Diagnosis Market (2026–2032)
The table below links each growth driver to the segment it affects and the evidence for it.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Growing prevalence of viral infections | Viral Infections | This trend drives hospitals to increase their procurement of diagnostic kits, with a reported 39% market share in 2025. |
| Government initiatives promoting PCR testing | PCR Kits | The National Health Commission's initiatives are projected to support the adoption of PCR kits, improving disease monitoring. |
| Rising demand for blood and plasma testing | Blood / Plasma | Due to the increasing incidence of chronic diseases, demand for these samples is on the rise, impacting healthcare providers. |
| Expansion of laboratory infrastructure | Laboratory Distributors | The presence of over 30,000 licensed medical laboratories enhances the distribution network for diagnostic products, facilitating access. |
| Increased adoption of rapid antigen tests | Rapid Antigen Tests | These tests are widely used in urban hospitals and clinics, contributing to a growing market share. |
Growth in the Infection Diagnosis market in China is driven by the rising incidence of chronic diseases, increased funding for healthcare infrastructure, and a heightened demand for rapid testing solutions. In 2022, over 1.4 billion people stimulated the need for infection diagnostics. The expansion of laboratory infrastructure, featuring more than 30,000 licensed medical laboratories, facilitates the distribution of diagnostic products. Rapid antigen tests have gained traction in urban hospitals, further boosting market demand. The promotion of PCR kits under the National Health Plan is expected to improve disease monitoring capabilities across healthcare facilities.
Evaluation of Restraints in China Infection Diagnosis Market
The following restraints limit how fast demand can grow.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory challenges in product approvals | PCR Kits | The China Food and Drug Administration's stringent regulations can delay the introduction of new diagnostic kits, affecting supply and availability. |
| Limited access to advanced technologies in rural areas | ELISA Test Kits | Healthcare facilities in rural regions often struggle to obtain the latest diagnostic technologies, impacting testing capabilities and patient care. |
| Quality control issues among suppliers | PCR Kits | Maintaining high product quality and safety standards is challenging for many suppliers in the market, affecting their competitiveness. |
| High costs associated with advanced diagnostic equipment | Culture Media & Kits | The investment required for sophisticated diagnostic technologies can deter smaller healthcare providers from upgrading their systems. |
| Inconsistent demand patterns across regions | Blood / Swab | Variability in infection rates leads to fluctuating demand for blood and swab samples, complicating inventory management for suppliers. |
China Infection Diagnosis Market Challenges
Buyers and suppliers in the China infection diagnosis market face intense competition, which drives prices down and squeezes profit margins for producers. This rivalry arises from over 30,000 licensed medical laboratories, creating a saturated environment that pressures pricing strategies. Skills shortages among laboratory technicians hinder effective testing and analysis, leading to delays in diagnosis for hospitals and clinics, which can extend patient wait times by up to 30%. The rising demand for blood and plasma samples due to chronic diseases strains resources, resulting in longer processing times for healthcare providers and affecting patient care. Compliance costs with standards like GB/T 19100-2019 burden suppliers, increasing operational expenses by approximately 15%.
Trends in the China Infection Diagnosis Market
Four trends stand out in the China Infection Diagnosis Market.
- Shift towards Rapid Testing Solutions: China is increasingly adopting rapid testing solutions, particularly in urban hospitals. Rapid antigen tests have seen widespread use, with a notable increase in demand over the past year, supporting faster diagnosis.
- Expansion of Online Diagnostic Sales Channels: Online diagnostic suppliers are gaining traction, particularly in urban areas. In the last year, online sales of diagnostic tests increased by 25%, indicating a shift in consumer purchasing behaviour towards convenience.
- Focus on Improving Laboratory Infrastructure: The Healthy China 2030 initiative aims to upgrade laboratory infrastructure nationwide. In 2023, the government allocated substantial funds to improve facilities, ensuring better diagnostic capabilities and access to testing.
- Adoption of Advanced Testing Technologies: The National Diagnostic Innovation Program initiated in 2022 supports research in rapid testing technologies. With a budget of 500 million RMB, this initiative aims to improve diagnostic capabilities across the country.
Investment Opportunities in the China Infection Diagnosis Market
Below are the investment opportunities with the strongest case in the China Infection Diagnosis Market.
- Growing Market for Rapid Testing: With the increasing prevalence of infections, there is an opportunity to invest in rapid testing solutions. Hospitals and clinics are actively seeking these products, particularly in urban areas, creating a growing market for suppliers.
- Investment in Laboratory Infrastructure: The ongoing improvements in laboratory infrastructure present an opportunity for suppliers. The Healthy China 2030 initiative encourages partnerships with local distributors to enhance diagnostic capabilities across the healthcare sector.
- Expansion of Online Diagnostic Services: The surge in online sales channels for diagnostic tests creates a significant opportunity. Suppliers can collaborate with online platforms to reach a broader consumer base, capitalising on the 25% increase in online sales last year.
- Focus on Blood and Plasma Testing: The increasing demand for blood and plasma samples presents an opportunity for investment in these diagnostic areas. Collaborating with medical laboratories can facilitate entry into this growing market.
Government Initiatives in the China Infection Diagnosis Market
The 'Infection Control and Prevention Plan' launched by the National Health Commission in 2021 aims to improve diagnostic capabilities across hospitals nationwide. This plan focuses on enhancing the readiness of healthcare facilities to respond to infectious disease outbreaks. The 'Guidelines for the Registration of In Vitro Diagnostic Reagents' updated by the National Medical Products Administration in 2021 streamline approval processes, facilitating quicker access to essential diagnostic products for healthcare providers. These measures collectively support the growth of the infection diagnosis market by ensuring that products meet safety and efficacy standards.
In 2022, the Ministry of Science and Technology initiated the 'National Diagnostic Innovation Program' with a budget of 500 million RMB to support research in rapid testing technologies. This program aims to bolster the development of advanced diagnostic solutions. The 'Health Emergency Response Plan' introduced by the Ministry of Health in 2023 focuses on improving rapid testing during health emergencies, ensuring healthcare facilities are better prepared for outbreaks. These initiatives are essential for advancing the infection diagnosis market in China.
Future Insight of the China Infection Diagnosis Market
The China infection diagnosis market will evolve by 2032, primarily driven by government investments in laboratory infrastructure under the Healthy China 2030 initiative. This initiative will enhance testing capabilities, enabling hospitals and clinics to deliver faster and more accurate diagnoses. The promotion of diagnostic kits under the National Health Plan is expected to increase their usage, improving disease monitoring efforts. Online sales of diagnostic tests are anticipated to grow further, following a 25% increase last year, providing consumers with more accessible options.
Market Segmentation Analysis
The report offers a comprehensive study of the following market segments and their leading categories in the market.
By Diagnostic Type – PCR Kits Dominated, Rapid Antigen Tests Expected to Grow Fastest
According to Shubham Deep, Research Manager at 6Wresearch, with a 47% revenue share in 2025, PCR Kits was the largest diagnostic type category. PCR kits dominate the market share because they are vital for accurately detecting viral infections, particularly in healthcare settings like hospitals. Their endorsement by the National Health Commission under the National Health Plan 2021-2025 highlights their importance in infection diagnosis. Rapid Antigen Tests are set to record the highest CAGR in this split, 7.1% over 2026–2032. Rapid antigen tests are experiencing rapid growth as they offer quick results, fulfilling the urgent need for immediate diagnosis in various healthcare environments. Their widespread application in urban hospitals and clinics significantly contributes to this accelerating demand. Suppliers should focus on enhancing the availability of rapid antigen tests to meet the rising need for swift diagnostic solutions.
By Sample Type – Blood / Swab Dominated, Nasal / Saliva Expected to Grow Fastest
The largest sample type category in 2025 was Blood / Swab, with a 46% share of total revenue. Blood and swab samples dominate the market share as they are the standard sample types utilised in numerous diagnostic tests within healthcare environments. Their widespread application across more than 30,000 licensed medical laboratories in China highlights their importance in infection diagnosis. Over 2026–2032, Nasal / Saliva is expected to post the fastest growth, at a CAGR of 6.8%. Nasal and saliva samples are experiencing the fastest growth due to their frequent use in respiratory infection testing, particularly in response to recent health challenges. This trend indicates a shift towards less invasive testing methods that are preferred by both patients and healthcare providers. Buyers can expect greater accessibility to nasal and saliva testing options, improving patient comfort and compliance in diagnostic procedures.
By Infection Type – Viral Infections Dominated, Bacterial / Viral Expected to Grow Fastest
In 2025, Viral Infections led the infection type split with a 39% share. Viral infections represent the largest market share as they are a primary target for diagnostic testing, especially given ongoing public health initiatives. The government's commitment to improving testing protocols further solidifies the focus on viral diagnostics. Bacterial / Viral is projected to grow fastest, at a CAGR of 7.0% during 2026–2032. The segment for bacterial and viral infections is witnessing the fastest growth, driven by an increase in mixed infections and the necessity for comprehensive diagnostic solutions. This trend indicates a shift towards a more integrated approach to infection diagnosis, addressing multiple pathogens at once. Suppliers should consider developing tests capable of diagnosing both bacterial and viral infections simultaneously to capitalise on this growing market segment.
By Distribution Channel – Laboratory Distributors Dominated, Online Diagnostic Suppliers Expected to Grow Fastest
Laboratory Distributors held a 48% share of the China Infection Diagnosis Market by distribution channel in 2025. Laboratory distributors lead the market due to their essential role in supplying diagnostic products to healthcare facilities, capturing a substantial market share in the diagnostic supply chain. Their established networks ensure that critical diagnostic tools are efficiently delivered to end-users. The quickest growth will come from Online Diagnostic Suppliers, forecast to expand at a CAGR of 7.7% between 2026 and 2032. Online diagnostic suppliers are rapidly becoming a prominent distribution channel, as evidenced by a 25% increase in online sales of diagnostic tests over the past year. This trend reflects a shift in consumer preferences towards more accessible and convenient testing options. Suppliers should strengthen their online strategies to cater to the increasing demand for diagnostic products through digital platforms.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Infection Diagnosis Market Outlook
- Market Size of China Infection Diagnosis Market, 2025
- Forecast of China Infection Diagnosis Market, 2032
- Historical Data and Forecast of China Infection Diagnosis Revenues & Volume for the Period 2022 - 2032F
- China Infection Diagnosis Market Trend Evolution
- China Infection Diagnosis Market Drivers and Challenges
- China Infection Diagnosis Price Trends
- China Infection Diagnosis Porter's Five Forces
- China Infection Diagnosis Industry Life Cycle
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Diagnostic Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Rapid Antigen Tests for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By PCR Kits for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By ELISA Test Kits for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Culture Media & Kits for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Sample Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Nasal / Saliva for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Blood / Swab for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Blood / Plasma for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Tissue / Swabs for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Infection Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Viral Infections for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Bacterial / Viral for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Fungal / Bacterial for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Anaerobic Infections for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Distribution Channel for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Pharmacies for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Laboratory Distributors for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Online Diagnostic Suppliers for the Period 2022 - 2032F
- Historical Data and Forecast of China Infection Diagnosis Market Revenues & Volume By Medical Labs Supply Chain for the Period 2022 - 2032F
- China Infection Diagnosis Import Export Trade Statistics
- Market Opportunity Assessment By Diagnostic Type
- Market Opportunity Assessment By Sample Type
- Market Opportunity Assessment By Infection Type
- Market Opportunity Assessment By Distribution Channel
- China Infection Diagnosis Top Companies Market Share
- China Infection Diagnosis Competitive Benchmarking By Technical and Operational Parameters
- China Infection Diagnosis Company Profiles
- China Infection Diagnosis Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Diagnostic Type
- Rapid Antigen Tests
- PCR Kits
- ELISA Test Kits
- Culture Media & Kits
By Sample Type
- Nasal / Saliva
- Blood / Swab
- Blood / Plasma
- Tissue / Swabs
By Infection Type
- Viral Infections
- Bacterial / Viral
- Fungal / Bacterial
- Anaerobic Infections
By Distribution Channel
- Pharmacies
- Laboratory Distributors
- Online Diagnostic Suppliers
- Medical Labs Supply Chain
